跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Gavlin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Gavlin
Approved
STANDARD
Gavlin
J.M. Tolamnn Laboratories Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
292c51583e127235
Company
J.M. Tolamnn Laboratories Inc.
Type
Standard
Approval Details
Approval Id
292c51583e127235
Drug Approval Philippines Name
Gavlin
Product Name
Gavlin
Registration Number
DRP-6278
Brand Name
Gavlin
Generic Name
Guaifenesin + Salbutamol (as sulfate)
Dosage Form
Capsule
Dosage Strength
100 mg / 2 mg
Manufacturer
J.M. Tolamnn Laboratories Inc.
Issuance Date
24 September 2022
Expiry Date
05 October 2027
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
292c51583e127235
Type
Standard
Back to Philippines FDA Approvals